Amgen Inc. (NASDAQ:AMGN) slightly down -0.12% to $170.63 with traded session volume was 2.01 Million. Amgen (AMGN) plans to highlight 19 abstracts on osteoporosis disease state and treatment at American Society for Bone and Mineral Research Yearly Meeting Sept 16-19. Prolia presentations will include additional analyses from the three-year FREEDOM trial and its seven-year extension, additional characterizing the long-term (up to 10 years) efficacy and safety of Prolia in postmenopausal women with osteoporosis, as well as real-world data showing long-term (two-year) persistence rates for Prolia and other osteoporosis therapies amid postmenopausal women. Osteoporosis disease-state study presentations will provide key insights on unmet needs amid patients at high risk for fracture. Romosozumab is being co-developed by Amgen and UCB. As concerns of stock price volatility, it was 1.21% for a week and 1.40% for a month.
Can Amgen Inc. becomes the newest Buy stock following this news? Find Out Here Totally Free
Stocks of Malibu Boats, Inc. (NASDAQ:MBUU) appeared in active trade move, surged 7.69% to trade at $14.98 in last session with shares volume of 305851. KEMET Corporation (NYSE:KEM) reported that it will be presenting at the Deutsche Bank 24th Yearly Leveraged Finance Conference in Scottsdale, Arizona on September 27, 2016 at 9:20 AM MST.
In the news release, “Malibu Boats, Inc. Reported FOURTH QUARTER and Fiscal Year 2016 Results,” issued earlier recently by Malibu Boats, Inc. (NASDAQ: MBUU), we are advised by the firm that the Conference ID under the Webcast and Conference Call Information should read “Conference ID #66215498” rather than “Conference ID #32499875” as originally issued. Complete corrected text follows. Malibu Boats, Inc. Reported FOURTH QUARTER and Fiscal Year 2016 Results. LOUDON, TN Malibu Boats, Inc. (NASDAQ: MBUU) recently reported its financial results for the fourth quarter and fiscal year ended June 30, 2016. To taking a short look on firm’s performance of margin, it showed a positive 8.10% in the net profit margin and in addition to its operating margin, which remained 15.90%.
Will Malibu Boats, Inc. retains its glamour following this report? Find Out Here
Align Technology Inc. (NASDAQ:ALGN) jumped up 1.08% during the previous trading session as the firm held price to earnings ratio of 46.81. Align Technology, Inc. (NASDAQ:ALGN) reported that 4 million patients have now started treatment with Invisalign, the most technically advanced clear aligner system in the world. This is a important accomplishment for the firm and the 100,000 Invisalign-trained doctors about the world, demonstrating surged global acceptance of Invisalign treatment as a preferred choice for straightening your teeth. “We are very proud to now have 4 million people who have begun treatment with Invisalign clear aligners instead of metal braces,” stated Joe Hogan, Align Technology president and CEO.
Can investors take a chance on buying ALGN this week? Find Inside Facts Here